S

Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250

Watchlist Manager
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Watchlist
Price: 169 000 KRW 3.11% Market Closed
Market Cap: 4T KRW
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+68%
Revenue
Forecast
-1%
Operating Income
Forecast
-6%
Net Income
Forecast
N/A

Wall Street
Price Targets

Price Targets Summary
Sam Chun Dang Pharm Co Ltd

There are no price targets for Sam Chun Dang Pharm Co Ltd.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sam Chun Dang Pharm Co Ltd Competitors:
Price Targets
2161
Jbm (Healthcare) Ltd
5% Downside
4519
Chugai Pharmaceutical Co Ltd
15% Upside
ALKEM
Alkem Laboratories Ltd
9% Upside
O
ORNBV
Orion Oyj
7% Downside
2161
Jbm (Healthcare) Ltd
5% Downside
4519
Chugai Pharmaceutical Co Ltd
15% Upside
ALKEM
Alkem Laboratories Ltd
9% Upside
O
ORNBV
Orion Oyj
7% Downside
Z
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
10% Upside
234080
JW Life Science Corp
32% Upside
D
DPHARMA
Duopharma Biotech Bhd
15% Upside
S
SDZ
Sandoz Group AG
2% Upside

Revenue
Forecast

Revenue Estimate
Sam Chun Dang Pharm Co Ltd

For the last 8 years the compound annual growth rate for Sam Chun Dang Pharm Co Ltd's revenue is 5%. The projected CAGR for the next 4 years is -2%.

5%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sam Chun Dang Pharm Co Ltd

For the last 8 years the compound annual growth rate for Sam Chun Dang Pharm Co Ltd's operating income is -24%. The projected CAGR for the next 4 years is 51%.

-24%
Past Growth
51%
Estimated Growth
Estimates Accuracy
-29%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sam Chun Dang Pharm Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Sam Chun Dang Pharm Co Ltd's stock price target?
Not Available

Sam Chun Dang Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Sam Chun Dang Pharm Co Ltd's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Sam Chun Dang Pharm Co Ltd's revenue is 5%. The projected CAGR for the next 4 years is -2%.

What is Sam Chun Dang Pharm Co Ltd's Operating Income forecast?
Projected CAGR
51%

For the last 8 years the compound annual growth rate for Sam Chun Dang Pharm Co Ltd's operating income is -24%. The projected CAGR for the next 4 years is 51%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.